Lisa A Nalley

Lisa A Nalley sold 35,000 BTSG shares at $58.75 ($2.1M); retains 131,948 shares + 41,909 stock options.

Lisa A Nalley sold 35,000 shares of BrightSpring Health Services on 2026-06-05 at $58.75, reducing her non-derivative holdings from 166,948 to 131,948 shares (-21.0%). The sale occurred near the 52-week high ($62.11), with the stock currently trading 7.6% below that peak. While her prior open-market sell at this ticker (2026-03-04) was followed by strong 90-day returns of +44.2%, the timing pattern at BTSG shows that prior sale was not well-timed for directional prediction. The company demonstrates solid fundamentals with $3.6B quarterly revenue, $148.8M net income, and +14.6% annual revenue growth, though the P/E of 35.88 reflects premium valuation. Nalley's remaining stake of 131,948 shares plus 41,909 exercisable stock options indicates she maintains material exposure to the company's performance.

Nalley sold 30,000 BTSG shares at $41.15 on 2026-03-04; retains 131,948 shares post-transaction.

Lisa A Nalley sold 30,000 shares of BrightSpring Health Services for $1,234,500.00, reducing her stake from 161,948 to 131,948 shares (-18.5% of pre-transaction holdings). The sale occurred near the company's 52-week high of $41.96, with the stock at $41.49 currently. BrightSpring is a substantial healthcare provider ($3.3B in latest quarterly revenue, $8.0B market cap) with healthy fundamentals—14.6% annual revenue growth and $55.8M in net income—suggesting operational stability. The executive's retention of 131,948 shares demonstrates continued meaningful ownership despite the reduction.